Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters.

Project label : alphabetical listings by drug labeler.
Published: (1979)

Project label : alphabetical listings by drug distributors.
Published: (1976)

FDA and RU-486 : Lowering the Standard for Women's Health.
Published: (2006)

Off-label use of prescription drugs : January 1986 through December 1992 : 103 citations /
by: Van de Kamp, Jacqueline
Published: (1992)

Project label : alphabetical listing by drug product.
Published: (1979)

Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394).
Published: (2002)

RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006.
Published: (2007)

RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006.
Published: (2007)

Project label : alphabetical listings of controlled generic drug ingredients.
Published: (1979)

Food labeling : FDA needs to reassess its approach to protecting consumers from false or misleading claims : report to congressional committees.
Published: (2011)

Foods, Drugs, and Cosmetics : hearings before the United States Senate Committee on Commerce, Subcommittee on S. 5, Seventy-Fourth Congress, first session, on Mar. 2, 8, 9, 1935.
Published: (1935)

Standardizing medication labels : confusing patients less : workshop summary /
Published: (2008)

"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978.
Published: (1978)

Prescription drug labels : actions needed to increase awareness of best practices for accessible labels for individuals who are blind or visually impaired : report to congressional addressees.
Published: (2016)

Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
Published: (2016)

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.
Published: (1998)

On-site drug testing /
Published: (2002)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Food labeling : FDA needs to better leverage resources, improve oversight, and effectively use available data to help consumers select healthy foods : report to the Chair, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives.
Published: (2008)

Workplace drug testing : a handbook for managers and in-house counsel /
by: McCloskey, Kevin L.
Published: (1995)

Drug testing in the workplace /
Published: (1989)

Cutting edge issues in drug testing and drug treatment : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 5, 1998.
Published: (1999)

Food and Drug Administration : agency complied with statutory requirement to reexamine condom labels.
by: King, Kathleen
Published: (2008)

A comparison of urinalysis technologies for drug testing in criminal justice /
by: Visher, Christy Ann
Published: (1991)

What you need to know about drug testing in schools.
Published: (2002)

A comparison of urinalysis technologies for drug testing in criminal justice /
by: Visher, Christy Ann
Published: (1991)

Guidance for industry : referencing discontinued labeling for listed drugs in abbreviated new drug applications.
Published: (2000)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

U.S. Food and Drug Administration announcement related to certain sleep disorder drugs.
Published: (2007)

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.
Published: (1997)

FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)

Off-label prescribing : justifying unapproved medicine /
by: Cavalla, David
Published: (2015)

Corporate America and the war on drugs : the importance of drug testing : hearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, June 27, 1996.
Published: (1997)

Trends in off-label drug use in ambulatory settings, 2006-2015 /
Published: (2019)

Drug testing : the experience of the transportation industry /
by: McCallion, Gail
Published: (1989)

Food and Drug Administration : FDA faces challenges meeting its growing medical product responsibilities and should develop complete estimates of its resource needs : report to congressional requesters.
Published: (2009)